Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Letai

Showing results (141-150 of 182) with videos related to

Pageof 19
Sort By:
Science Signaling|June 9, 2021
Metabolic perturbations sensitize triple-negative breast cancers to apoptosis induced by BH3 mimeticsVeerle W Daniels, Jason J Zoeller, Nick van Gastel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2014
Cell and molecular determinants of in vivo efficacy of the BH3 mimetic ABT-263 against pediatric acute lymphoblastic leukemia xenograftsSanti Suryani, Hernan Carol, Triona Ni Chonghaile, et al.
Cancer Research|December 21, 2017
ER Stress Signaling Promotes the Survival of Cancer "Persister Cells" Tolerant to EGFR Tyrosine Kinase InhibitorsHideki Terai, Shunsuke Kitajima, Danielle S Potter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A phase 1 dose-escalation study of Navitoclax, Venetoclax, and DecitabineEvan C Chen, Yiwen Liu, Hayden L Bell, et al.
Nature Medicine|October 17, 2017
Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastomaWilson X Mai, Laura Gosa, Veerle W Daniels, et al.
Cancer Cell|November 20, 2020
Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid LeukemiaShruti Bhatt, Marissa S Pioso, Elyse Anne Olesinski, et al.
Cancer Discovery|September 17, 2021
An <i>In Vivo</i> CRISPR Screening Platform for Prioritizing Therapeutic Targets in AMLShan Lin, Clément Larrue, Nastassja K Scheidegger, et al.
Cancer Cell|December 27, 2016
Developmental Regulation of Mitochondrial Apoptosis by c-Myc Governs Age- and Tissue-Specific Sensitivity to Cancer TherapeuticsKristopher A Sarosiek, Cameron Fraser, Nathiya Muthalagu, et al.
Cancer Discovery|September 11, 2012
Reactivation of ERK signaling causes resistance to EGFR kinase inhibitorsDalia Ercan, Chunxiao Xu, Masahiko Yanagita, et al.
Cell Death and Differentiation|December 26, 2025
Drug-tolerant persisters and immunotherapy persister cells exhibit cross-resistance and share common survival mechanismsMaria Davern, Cole J Turner, Daryl Griffin, et al.
Pageof 19

Showing results (141-150 of 182) with videos related to

Sort By:
Pageof 19
Science Signaling|June 9, 2021
Metabolic perturbations sensitize triple-negative breast cancers to apoptosis induced by BH3 mimeticsVeerle W Daniels, Jason J Zoeller, Nick van Gastel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2014
Cell and molecular determinants of in vivo efficacy of the BH3 mimetic ABT-263 against pediatric acute lymphoblastic leukemia xenograftsSanti Suryani, Hernan Carol, Triona Ni Chonghaile, et al.
Cancer Research|December 21, 2017
ER Stress Signaling Promotes the Survival of Cancer "Persister Cells" Tolerant to EGFR Tyrosine Kinase InhibitorsHideki Terai, Shunsuke Kitajima, Danielle S Potter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A phase 1 dose-escalation study of Navitoclax, Venetoclax, and DecitabineEvan C Chen, Yiwen Liu, Hayden L Bell, et al.
Nature Medicine|October 17, 2017
Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastomaWilson X Mai, Laura Gosa, Veerle W Daniels, et al.
Cancer Cell|November 20, 2020
Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid LeukemiaShruti Bhatt, Marissa S Pioso, Elyse Anne Olesinski, et al.
Cancer Discovery|September 17, 2021
An <i>In Vivo</i> CRISPR Screening Platform for Prioritizing Therapeutic Targets in AMLShan Lin, Clément Larrue, Nastassja K Scheidegger, et al.
Cancer Cell|December 27, 2016
Developmental Regulation of Mitochondrial Apoptosis by c-Myc Governs Age- and Tissue-Specific Sensitivity to Cancer TherapeuticsKristopher A Sarosiek, Cameron Fraser, Nathiya Muthalagu, et al.
Cancer Discovery|September 11, 2012
Reactivation of ERK signaling causes resistance to EGFR kinase inhibitorsDalia Ercan, Chunxiao Xu, Masahiko Yanagita, et al.
Cell Death and Differentiation|December 26, 2025
Drug-tolerant persisters and immunotherapy persister cells exhibit cross-resistance and share common survival mechanismsMaria Davern, Cole J Turner, Daryl Griffin, et al.
Pageof 19